PEGCX | VMGMX | PEGCX / VMGMX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 28 years | 13 years | - |
Gain YTD | -3.992 | 2.315 | -172% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.35B | 29.7B | 8% |
Annual Yield % from dividends | 0.00 | 0.68 | - |
Returns for 1 year | -4.28 | 13.30 | -32% |
Returns for 3 years | -0.26 | 20.38 | -1% |
Returns for 5 years | -56.31 | 74.51 | -76% |
Returns for 10 years | -85.87 | 145.77 | -59% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
NSNCX | 45.25 | 0.75 | +1.69% |
Neuberger Berman Small Cap Growth C | |||
MSHMX | 13.60 | 0.18 | +1.34% |
Morgan Stanley Inst Permanence I | |||
JFNAX | 70.00 | 0.84 | +1.21% |
Janus Henderson Global Life Sciences A | |||
MCILX | 18.61 | 0.18 | +0.98% |
BlackRock International Inv C | |||
EPVIX | 11.24 | 0.02 | +0.18% |
EuroPac International Value I |